Cusack Thomas has filed 3 insider transactions across 1 company since November 2025.
Most recent transaction: a grant/award of 53960 shares of HERON THERAPEUTICS, INC. /DE/ ($HRTX) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Cusack Thomas | Not found | A | Common Stock | 53960 | $0.00 | 53,960.0000 | 183,362,522 | 9999.99% | 0.03% |
| Nov. 8, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Cusack Thomas | Not found | A | Common Stock | 37879 | $0.00 | 37,879.0000 | 183,362,522 | 9999.99% | 0.02% |
| Nov. 8, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Cusack Thomas | Not found | A | Stock Option (Right to Buy) | 227272 | $1.10 | 227,272.0000 | 183,362,522 | 9999.99% | 0.12% |